Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bouwhuis Enthoven is a prominent Dutch manufacturer specializing in the production and processing of high-quality egg-based ingredients for the food and pharmaceutical sectors. The company provides a wide range of products, including liquid, concentrated, and dried egg components, with a specific focus on functional proteins like lysozyme. Lysozyme is extracted from egg whites and supplied to the pharmaceutical industry for its natural antimicrobial properties, often used in medicines to treat throat infections or as a preservative in medical applications. Operating as part of the Van Beek Group, Bouwhuis Enthoven utilizes advanced spray-drying and pasteurization technologies to meet rigorous international safety and quality standards. Their facilities in the Netherlands serve a global clientele, positioning them as a critical supplier in the life sciences supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bouwhuis Enthoven.